Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ERIC D ADLER

Allopathic & Osteopathic Physicians Internal Medicine Advanced Heart Failure and Transplant Cardiology

NPI
1477699601
CMS profile
66583
Location
SAN DIEGO, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$8,359.84

30 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Travel and Lodging $3,228.93 4
Consulting Fee $3,015.00 1
Food and Beverage $2,115.91 25

By paying entity

PY2022 · entire year · sorted by reported total

Page 1 of 1; records 1–30 of 30 matching records. This page contains 30 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ERIC D ADLER

NPI 1477699601 · CMS profile ID 66583

Allopathic & Osteopathic Physicians / Internal Medicine / Advanced Heart Failure and Transplant Cardiology

SAN DIEGO, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–30 of 30 matching records. This page contains 30 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1477699601?year=2022&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ERIC D ADLER, NPI 1477699601, CMS profile ID 66583. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–30 of 30 matching records. This page contains 30 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1477699601?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). ERIC D ADLER, NPI 1477699601, CMS profile ID 66583. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–30 of 30 matching records. This page contains 30 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1477699601?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
ERIC D ADLER, NPI 1477699601, CMS profile ID 66583, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–30 of 30 matching records. This page contains 30 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1477699601?year=2022&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

30 matching records · $8,359.84 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 30 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–30 of 30.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Abbott Laboratories $23.1212/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908640439 CMS
Abbott Laboratories $155.6612/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 907927257 CMS
Abbott Laboratories $23.5511/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 910329807 CMS
Kiniksa Pharmaceuticals, Ltd. $1,913.5011/22/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 957797067 CMS
Kiniksa Pharmaceuticals, Ltd. $3,015.0011/22/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 957797147 CMS
Abbott Laboratories $154.2410/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908640409 CMS
Abbott Laboratories $700.6410/19/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908640425 CMS
Abbott Laboratories $90.9010/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908640455 CMS
Abbott Laboratories $128.0910/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908640461 CMS
Abbott Laboratories $139.6110/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908640469 CMS
Abbott Laboratories $33.0510/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 907927263 CMS
Abbott Laboratories $160.2809/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920479805 CMS
Abbott Laboratories $102.8809/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 907927265 CMS
Abbott Laboratories $143.1708/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908640403 CMS
Abbott Laboratories $31.6608/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908640445 CMS
AstraZeneca Pharmaceuticals LP $20.9808/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914690007 CMS
Abbott Laboratories $165.2507/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 907927259 CMS
Abbott Laboratories $24.7107/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 907927261 CMS
Impulse Dynamics (USA) Inc. $108.1506/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947546245 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $31.4706/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 876357465 CMS
Abbott Laboratories $147.5706/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914213889 CMS
Abbott Laboratories $605.1206/20/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908640417 CMS
ABIOMED $148.3606/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942014619 CMS
Abbott Laboratories $62.3806/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920479813 CMS
Abbott Laboratories $46.5305/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920474597 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $21.0405/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 876357463 CMS
Abbott Laboratories $85.6303/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914213895 CMS
Abbott Laboratories $9.6703/26/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908640433 CMS
Cardiovascular Systems Inc. $29.0503/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947931281 CMS
Cardiovascular Systems Inc. $38.5801/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947907447 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $11,331.49 43
PY2020 $786.16 7
PY2021 $664.17 8
PY2022 $8,359.84 30
PY2023 $780.80 9
PY2024 $571.09 7
PY2025 $1,023.61 11

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $286,851.05 9
PY2024 Principal investigator $394,153.44 12
PY2023 Principal investigator $240,908.88 22
PY2022 Principal investigator $71,817.41 20
PY2021 Principal investigator $106,137.09 19
PY2020 Recipient $1,270.00 2
PY2020 Principal investigator $128,351.75 33
PY2019 Principal investigator $110,079.18 31

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

31 records in PY2019

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Medtronic Vascular, Inc. $374.55 12/31/2019 Non-covered Recipient Entity
Regents Of The University Of California
PSR-MCS No dispute reported 06/30/2026 660581741
Principal investigator 1 Abbott Laboratories $747.00 12/13/2019 Non-covered Recipient Entity
Western Institutional Review Board
Multi-Center Study of MagLev Technology in Patients Undergoing MCS Therapy with HeartMate 3 Continued Access Protocol No dispute reported 06/30/2026 703424959
Principal investigator 1 Abbott Laboratories $500.00 12/12/2019 Non-covered Recipient Entity
Regents of the University of California The
Multi-Center Study of MagLev Technology in Patients Undergoing MCS Therapy with HeartMate 3 Continued Access Protocol No dispute reported 06/30/2026 703424801
Principal investigator 1 Medtronic Vascular, Inc. $750.00 12/05/2019 Non-covered Recipient Entity
Ucsd Medical Group
PSR-MCS No dispute reported 06/30/2026 660579901
Principal investigator 1 Medtronic Vascular, Inc. $700.00 12/04/2019 Non-covered Recipient Entity
Nelson Adler Inc
PSR-MCS No dispute reported 06/30/2026 660579211
Principal investigator 1 Medtronic Vascular, Inc. $350.00 12/04/2019 Non-covered Recipient Entity
Nelson Adler Inc
PSR-MCS No dispute reported 06/30/2026 660579215
Principal investigator 1 Abbott Laboratories $1,260.00 11/28/2019 Non-covered Recipient Entity
Regents of the University of California The
Multi-Center Study of MagLev Technology in Patients Undergoing MCS Therapy with HeartMate 3 Continued Access Protocol No dispute reported 06/30/2026 703425937
Principal investigator 1 Abbott Laboratories $1,514.00 11/22/2019 Non-covered Recipient Entity
Western Institutional Review Board
MOMENTUM 3 Extended Follow-up Post Approval Study No dispute reported 06/30/2026 703426147
Principal investigator 1 PFIZER INC. $14,040.00 11/22/2019 Non-covered Recipient Entity
REGENTS OF THE UNIV OF CALIF
A PHASE 3 MULTICENTER RANDOMIZED DOUBLEBLIND EXTENSION STUDY TO EVALUATE THE SAFETY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE PF06291826 20 MG OR 80 MG IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY TTRCM No dispute reported 06/30/2026 671681875
Principal investigator 1 PFIZER INC. $750.00 11/22/2019 Non-covered Recipient Entity
REGENTS OF THE UNIV OF CALIF
A PHASE 3 MULTICENTER RANDOMIZED DOUBLEBLIND EXTENSION STUDY TO EVALUATE THE SAFETY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE PF06291826 20 MG OR 80 MG IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY TTRCM No dispute reported 06/30/2026 671681933
Principal investigator 1 PFIZER INC. $1,300.00 11/22/2019 Non-covered Recipient Entity
REGENTS OF THE UNIV OF CALIF
A PHASE 3 MULTICENTER RANDOMIZED DOUBLEBLIND EXTENSION STUDY TO EVALUATE THE SAFETY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE PF06291826 20 MG OR 80 MG IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY TTRCM No dispute reported 06/30/2026 671681935
Principal investigator 1 PFIZER INC. $15,767.86 11/05/2019 Non-covered Recipient Entity
REGENTS OF THE UNIV OF CALIF
A PHASE 3 MULTICENTER RANDOMIZED DOUBLEBLIND EXTENSION STUDY TO EVALUATE THE SAFETY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE PF06291826 20 MG OR 80 MG IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY TTRCM No dispute reported 06/30/2026 671681931
Principal investigator 1 Abbott Laboratories $16,587.00 10/30/2019 Non-covered Recipient Entity
Regents of the University of California The
Multi-Center Study of MagLev Technology in Patients Undergoing MCS Therapy with HeartMate 3 Continued Access Protocol No dispute reported 06/30/2026 703422559
Principal investigator 1 Abbott Laboratories $1,560.00 10/24/2019 Non-covered Recipient Entity
Western Institutional Review Board
Multi-Center Study of MagLev Technology in Patients Undergoing MCS Therapy with HeartMate 3 Continued Access Protocol No dispute reported 06/30/2026 703422833
Principal investigator 1 Abbott Laboratories $200.00 09/12/2019 Non-covered Recipient Entity
Regents of the University of California The
Multi-Center Study of MagLev Technology in Patients Undergoing MCS Therapy with HeartMate 3 Continued Access Protocol No dispute reported 06/30/2026 703420653
Principal investigator 1 Medtronic Vascular, Inc. $11,510.00 09/12/2019 Non-covered Recipient Entity
Ucsd Medical Group
PSR-MCS No dispute reported 06/30/2026 660579897
Principal investigator 1 Abbott Laboratories $1,260.00 08/22/2019 Non-covered Recipient Entity
Regents of the University of California The
Multi-Center Study of MagLev Technology in Patients Undergoing MCS Therapy with HeartMate 3 Continued Access Protocol No dispute reported 06/30/2026 703418697
Principal investigator 1 PFIZER INC. $3,250.00 08/20/2019 Non-covered Recipient Entity
REGENTS OF THE UNIV OF CALIF
A PHASE 3 MULTICENTER RANDOMIZED DOUBLEBLIND EXTENSION STUDY TO EVALUATE THE SAFETY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE PF06291826 20 MG OR 80 MG IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY TTRCM No dispute reported 06/30/2026 671681645
Principal investigator 1 Abbott Laboratories $12,894.00 07/24/2019 Non-covered Recipient Entity
Regents of the University of California The
Multi-Center Study of MagLev Technology in Patients Undergoing MCS Therapy with HeartMate 3 Continued Access Protocol No dispute reported 06/30/2026 703417179
Principal investigator 1 LivaNova USA, Inc. $1,260.00 07/09/2019 Covered Recipient Teaching Hospital
UCSD MEDICAL CENTER
Theme No dispute reported 06/30/2026 703216919
Principal investigator 1 LivaNova USA, Inc. $5,166.00 07/09/2019 Covered Recipient Teaching Hospital
UCSD MEDICAL CENTER
Theme No dispute reported 06/30/2026 703216921
Principal investigator 1 Abbott Laboratories $45.00 06/30/2019 Non-covered Recipient Entity
Regents of the University of California The
Hemodynamic Guided Monitoring in Heart Failure (HF) Trial (GUIDE-HF) No dispute reported 06/30/2026 703416617
Principal investigator 1 Medtronic Vascular, Inc. $374.55 06/30/2019 Non-covered Recipient Entity
Regents Of The University Of California
PSR-MCS No dispute reported 06/30/2026 660581249
Principal investigator 1 PFIZER INC. $138.94 06/18/2019 Non-covered Recipient Entity
REGENTS OF THE UNIV OF CALIFORNIA
A PHASE 3 MULTICENTER RANDOMIZED DOUBLEBLIND EXTENSION STUDY TO EVALUATE THE SAFETY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE PF06291826 20 MG OR 80 MG IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY TTRCM No dispute reported 06/30/2026 671657775
Principal investigator 1 Abbott Laboratories $4,131.00 05/08/2019 Non-covered Recipient Entity
Regents of the University of California The
Multi-Center Study of MagLev Technology in Patients Undergoing MCS Therapy with HeartMate 3 Continued Access Protocol No dispute reported 06/30/2026 703415781
Principal investigator 1 Abbott Laboratories $28.00 04/11/2019 Non-covered Recipient Entity
Regents of the University of California San Diego
HM3 SWIFT Study No dispute reported 06/30/2026 750803425
Principal investigator 1 PFIZER INC. $1,070.75 04/02/2019 Non-covered Recipient Entity
REGENTS OF THE UNIV OF CALIFORNIA
A PHASE 3 MULTICENTER RANDOMIZED DOUBLEBLIND EXTENSION STUDY TO EVALUATE THE SAFETY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE PF06291826 20 MG OR 80 MG IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY TTRCM No dispute reported 06/30/2026 671657519
Principal investigator 1 Abbott Laboratories $9,534.00 01/30/2019 Non-covered Recipient Entity
Regents of the University of California The
Multi-Center Study of MagLev Technology in Patients Undergoing MCS Therapy with HeartMate 3 Continued Access Protocol No dispute reported 06/30/2026 703410605
Principal investigator 1 Abbott Laboratories $1,377.00 01/23/2019 Non-covered Recipient Entity
Regents of the University of California The
Multi-center study of MagLev Technology in Patients Undergoing MCS Therapy with Heartmate 3 No dispute reported 06/30/2026 703410603
Principal investigator 1 Abbott Laboratories $294.00 01/11/2019 Non-covered Recipient Entity
Western Institutional Review Board
Multi-center study of MagLev Technology in Patients Undergoing MCS Therapy with Heartmate 3 No dispute reported 06/30/2026 703410863
Principal investigator 1 PFIZER INC. $1,345.53 01/03/2019 Non-covered Recipient Entity
REGENTS OF THE UNIV OF CALIFORNIA
A PHASE 3 MULTICENTER RANDOMIZED DOUBLEBLIND EXTENSION STUDY TO EVALUATE THE SAFETY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE PF06291826 20 MG OR 80 MG IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY TTRCM No dispute reported 06/30/2026 671653849